NEW YORK, August 9, 2026, 15:06 EDT
- IBM rose 6.09% over the past week, outperforming the Nasdaq Composite by 0.90 percentage point.
- The rolling analyst target dropped 13.3% over the past month to $265.40, while the consensus rating stayed at Moderate Buy.
- The $1.69 ex-dividend adjustment set for Monday represents 0.71% of Friday’s closing price. The theoretical level is $235.59, which is not a projection.
International Business Machines Corporation NYSE:IBM starts Monday following a 6.1% gain over the past week. However, consensus price targets from Wall Street have dropped by 13.3% in the past month.
That serves as an indicator for investors. Analysts maintained a Moderate Buy consensus but reduced the price target to $265.40. This suggests a potential upside of roughly 11.9% compared to Friday’s closing price.
U.S. markets in New York did not open on Sunday. IBM closed Friday trading at $237.28, rising 1.65%. Shares were still trading 28.6% under their high from June 2.
IBM’s rebound is highlighted in Friday’s cross-market summary.
| Asset | Friday close | Friday move | Weekly move |
|---|---|---|---|
| IBM | $237.28 | up 1.65% | up 6.09% |
| S&P 500 | 7,757.64 | gained 0.62% | rose 3.58% |
| Nasdaq Composite | 26,690.62 | advanced 1.30% | up 5.19% |
| Dow Jones Industrial Average | 54,036.93 | increased 0.28% | gained 2.96% |
Last week, IBM outperformed the Nasdaq by 0.90 percentage point and exceeded the S&P 500 by 2.51 points. This happened as markets broadly rallied following softer U.S. jobs figures that eased concerns about further interest rate hikes.
Trading activity slowed, with average daily IBM volume at 6.05 million shares, representing just 54.4% of its 65-day norm. This leaves the rebound less definitive than price action indicates.
The dividend set for Monday is expected to affect the opening price. IBM shares will begin trading ex-dividend by $1.69, with the payout scheduled for September 10. When the dividend is subtracted from Friday’s closing price, the adjusted reference stands at $235.59.
Recent post-earnings ratings indicate a broad range in valuations. The following implied returns are based on Friday’s close.
| Brokerage or consensus | Recommendation | Target | Implied move | Date |
|---|---|---|---|---|
| Susquehanna | Neutral | $225 | -5.2% | July 24 |
| Barclays PLC NYSE:BCS | Overweight | $262 | +10.4% | July 23 |
| Citigroup Inc. NYSE:C | Buy | $245 | +3.3% | July 23 |
| Morgan Stanley NYSE:MS | Equalweight | $190 | -19.9% | July 23 |
| The Goldman Sachs Group, Inc. NYSE:GS | Buy | $270 | +13.8% | July 23 |
| 27-analyst consensus | Moderate Buy | $265.40 | +11.9% | Current |
The average target price dropped by $40.88 over the past month. The number of buy ratings decreased from 16 to 15. Hold recommendations increased from nine to 11, with one sell rating emerging. This trend points to a repricing rather than widespread surrender.
CFRA analyst Brooks Idlet noted the decline “more likely to reflect specific IBM-related hardware issues.” He described the quarter as less negative for the broader software sector. Reuters
IBM’s second-quarter performance is still the key fundamental focus. The results have been confirmed. The comparisons referenced below come from consensus estimates by analysts or previous company forecasts.
| Metric | IBM result or outlook | Comparison | Gap or signal |
|---|---|---|---|
| Second-quarter revenue | $17.16 billion | $17.58 billion estimate | 2.4% lower |
| Adjusted earnings per share | $2.93 | $2.97 estimate | 1.3% short |
| Software revenue | $7.76 billion | $7.88 billion estimate | 1.5% under; 5% higher from a year ago |
| Infrastructure revenue | $3.84 billion | $4.14 billion a year earlier | 7.4% decrease; IBM Z dropped 42% |
| 2026 constant-currency revenue growth | 4%–5% | Previous outlook above 5% | Lowered |
| 2026 free-cash-flow growth | About $1 billion year on year | Previous outlook | Unchanged |
Chief Executive Arvind Krishna stated that roughly one-third of postponed deals were completed ahead of schedule during the third quarter. “A lot of the demand is deferred, not destroyed,” he said. Investors are waiting to see this reflected in software and mainframe revenue. Reuters
Valuation provides a degree of support, though not compared to all relevant peers. The reported market snapshot situates IBM between consulting and enterprise software.
| Company | Friday close | P/E ratio | Market capitalization | Friday change |
|---|---|---|---|---|
| IBM | $237.28 | 21.0 | $226.2 billion | +1.65% |
| Microsoft Corporation NASDAQ:MSFT | $499.99 | 29.8 | $3.72 trillion | +0.01% |
| Oracle Corporation NYSE:ORCL | $147.02 | 26.4 | $428.1 billion | +2.42% |
| Accenture plc NYSE:ACN | $175.72 | 14.0 | $108.2 billion | +2.68% |
IBM’s multiple sits approximately 29% lower than Microsoft’s and 20% below Oracle’s, yet still stands around 50% higher than Accenture’s. As a result, investors are pricing in more than just consulting services, but not as much as full-scale cloud growth.
IBM has not scheduled an investor event for this week. The company’s upcoming earnings release is tentatively set for October 21. Upcoming data includes Wednesday’s CPI, Thursday’s PPI, and Friday’s retail sales report.
Risks: Postponed deals risk further delays. Customers might continue to favor AI infrastructure instead of IBM software and mainframes. Strong inflation numbers may drive yields higher and weigh on the stock’s valuation.
On Monday, total return is more significant than the headline price. A move down to about $1.69 would mainly indicate the impact of the dividend. An increase in volume following this adjustment would give a clearer sign that IBM’s recovery is lasting.
Related articles: NYSE:IBM
